KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) EPS (Basic) (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed EPS (Basic) for 17 consecutive years, with $26.73 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 204.54% to $26.73 in Q4 2025 year-over-year; TTM through Dec 2025 was $27.87, a 142.88% increase, with the full-year FY2025 number at $27.87, up 142.64% from a year prior.
  • EPS (Basic) was $26.73 for Q4 2025 at Bio-Rad Laboratories, up from -$12.7 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $131.8 in Q3 2021 to a low of -$112.5 in Q1 2022.
  • A 5-year average of -$1.84 and a median of $2.99 in 2023 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): plummeted 442.36% in 2022, then soared 540.27% in 2024.
  • Bio-Rad Laboratories' EPS (Basic) stood at -$52.54 in 2021, then skyrocketed by 153.08% to $27.89 in 2022, then tumbled by 56.44% to $12.15 in 2023, then tumbled by 310.45% to -$25.57 in 2024, then surged by 204.54% to $26.73 in 2025.
  • Per Business Quant, the three most recent readings for BIO's EPS (Basic) are $26.73 (Q4 2025), -$12.7 (Q3 2025), and $11.55 (Q2 2025).